J. Goldman & Co LP Q4 2021 Filing

Filed February 14, 2022

Portfolio Value

$1.8T

Holdings

270

Report Date

Q4 2021

Filing Type

13F-HR

All Holdings (270 positions)

#StockSharesValue% PortfolioType
201
DONSPDR DOW JONES INDL AVERAGE
4,424$1.6B0.09%
202
NEW VISTA ACQUISITION CORP
234,842$1.6B0.09%Call
203
LIBERTY MEDIA ACQUISITION CO
154,536$1.6B0.09%
204
WARRIOR TECHNOLOGIES ACQUI C
154,500$1.6B0.09%
205
RRRRED ROCK RESORTS INC
28,250$1.6B0.09%Put
206
GLPGGALAPAGOS NV
27,972$1.5B0.08%
207
WNSNWNS HLDGS LTD
17,260$1.5B0.08%
208
TUATARA CAPITAL ACQUISITN CO
150,000$1.5B0.08%
209
AMPSUSDALTUS POWER INC
143,592$1.5B0.08%
210
CLARIM ACQUISITION CORP
150,000$1.5B0.08%
211
VY GLOBAL GROWTH
150,367$1.5B0.08%
212
METVLISTED FD TR
94,035$1.4B0.08%
213
ATHIRA PHARMA INC
108,200$1.4B0.08%
214
GQ9SPDR GOLD TR
8,250$1.4B0.08%
215
PRIMAVERA CAPITAL ACQUIST CO
203,670$1.4B0.08%Call
216
GEVOGEVO INC
317,538$1.4B0.07%Call
217
IVWISHARES TR
16,062$1.3B0.07%
218
TEKKORP DIGITAL ACQUISITN CO
200,770$1.3B0.07%Call
219
CORNER GROWTH ACQUISITION CO
253,746$1.3B0.07%Call
220
TZP STRATEGIES ACQUISTN CORP
118,750$1.2B0.06%
221
CWHCAMPING WORLD HLDGS INC
28,500$1.2B0.06%Put
222
LEVERE HOLDINGS CORP
99,384$990.0M0.05%
223
RZLTREZOLUTE INC
202,500$968.0M0.05%
224
COMPUTE HEALTH ACQUISITIN CO
120,475$959.0M0.05%Call
225
THUNDER BRIDGE CAP PRTNRS II
95,929$954.0M0.05%
226
ARWRARROWHEAD PHARMACEUTICALS IN
13,500$895.0M0.05%Call
227
DEDEERE & CO
2,594$889.0M0.05%
228
SUPERNOVA PARTNERS ACQUISTN
85,625$881.0M0.05%
229
TASTEMAKER ACQUISITION CORP
309,253$874.0M0.05%Call
230
IHRTIHEARTMEDIA INC
41,260$868.0M0.05%
231
MRUSMERUS N V
26,812$853.0M0.05%
232
PRQRPROQR THRAPEUTICS N V
102,120$818.0M0.05%
233
JETSETF SER SOLUTIONS
37,500$791.0M0.04%Put
234
PRIVETERRA ACQUISITION CORP
79,884$791.0M0.04%
235
EXECUTIVE NETWORK PARTNERING
92,880$741.0M0.04%Call
236
CRSRCORSAIR GAMING INC
34,625$727.0M0.04%
237
ARKKARK ETF TR
7,500$709.0M0.04%
238
RVNCEURREVANCE THERAPEUTICS INC
40,500$661.0M0.04%Put
239
KADEM SUSTAINABLE IMPACT COR
60,000$599.0M0.03%
240
DBDEURDIEBOLD NIXDORF INC
60,000$543.0M0.03%Put
241
HARPOON THERAPEUTICS INC
67,500$510.0M0.03%
242
RIGLUSDRIGEL PHARMACEUTICALS INC
191,839$508.0M0.03%
243
AKAMAKAMAI TECHNOLOGIES INC
4,227$495.0M0.03%
244
EXECUTIVE NETWORK PARTNERING
49,536$494.0M0.03%
245
IYRISHARES TR
3,978$462.0M0.03%
246
BBIOBRIDGEBIO PHARMA INC
27,000$450.0M0.02%Call
247
VINCERX PHARMA INC
43,101$439.0M0.02%
248
SPGSIMON PPTY GROUP INC NEW
2,708$433.0M0.02%
249
SHOPSHOPIFY INC
313$431.0M0.02%
250
FHTXFOGHORN THERAPEUTICS INC
18,738$429.0M0.02%
251
RESEARCH ALLIANCE CORP II
39,932$390.0M0.02%
252
XOPSPDR SER TR
3,750$360.0M0.02%
253
TORCEURADICET BIO INC
18,772$328.0M0.02%
254
INFYINFOSYS LTD
12,500$316.0M0.02%
255
RXR ACQUISITION CORP
31,559$312.0M0.02%
256
AMLPALPS ETF TR
8,667$284.0M0.02%
257
MLB1MERCADOLIBRE INC
151$204.0M0.01%
258
SOFISOFI TECHNOLOGIES INC
12,022$190.0M0.01%
259
COMPCOMPASS INC
17,473$159.0M0.01%
260
GBYSANGAMO THERAPEUTICS INC
20,500$154.0M0.01%Call
261
ADVADVANTAGE SOLUTIONS INC
59,871$148.0M0.01%Call
262
IMTXIMMATICS N.V
26,984$118.0M0.01%Call
263
MREOMEREO BIOPHARMA GROUP PLC
67,501$108.0M0.01%
264
WBXWALLBOX NV
16,876$84.0M0.00%Call
265
ONCOSEC MED INC
26,300$25.0M0.00%Call
266
MEDICUS SCIENCES ACQUISITION
33,333$23.0M0.00%Call
267
ADMAADMA BIOLOGICS INC
12,000$17.0M0.00%
268
PHGEBIOMX INC
150,000$15.0M0.00%Call
269
US WELL SERVICES INC
70,000$5.0M0.00%Call
270
PETROS PHARMACEUTICALS INC
31,250$00.00%Call
PreviousPage 3 of 3